Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine Lee

Showing results (111-120 of 113) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 113 results.
Journal for Immunotherapy of Cancer|September 4, 2021
Phase 1 open-label trial of intravenous administration of MVA-BN-brachyury-TRICOM vaccine in patients with advanced cancerPeter J DeMaria, Katherine Lee-Wisdom, Renee N Donahue, et al.
BMJ Open|September 21, 2025
Finding the optimal regimen for <i>Mycobacteroides abscessus</i> treatment (FOR<i>Ma</i>T) in people with <i>Mycobacteroides abscessus</i> pulmonary disease: a multicentre, randomised, multi-arm, adaptive platform trialTiffany Jong, Timothy Baird, Helen Louise Barr, et al.
European Heart Journal|March 20, 2023
Biomarkers and cardiovascular outcomes in chimeric antigen receptor T-cell therapy recipientsSyed S Mahmood, Peter A Riedell, Stephanie Feldman, et al.
Pageof 12

Showing results (111-120 of 113) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 113 results.
Journal for Immunotherapy of Cancer|September 4, 2021
Phase 1 open-label trial of intravenous administration of MVA-BN-brachyury-TRICOM vaccine in patients with advanced cancerPeter J DeMaria, Katherine Lee-Wisdom, Renee N Donahue, et al.
BMJ Open|September 21, 2025
Finding the optimal regimen for <i>Mycobacteroides abscessus</i> treatment (FOR<i>Ma</i>T) in people with <i>Mycobacteroides abscessus</i> pulmonary disease: a multicentre, randomised, multi-arm, adaptive platform trialTiffany Jong, Timothy Baird, Helen Louise Barr, et al.
European Heart Journal|March 20, 2023
Biomarkers and cardiovascular outcomes in chimeric antigen receptor T-cell therapy recipientsSyed S Mahmood, Peter A Riedell, Stephanie Feldman, et al.
Pageof 12